The cost of skin cancer treatments continue to increase in the United States where a large proportion of expenditures stem from the cost of systemic agents for melanoma.
Some melanoma patients prefer fewer follow-up visits, but only if self-skin examinations were utilized at home or teledermatology implemented for a quick assessment.
There are four questions physicians should ask when considering using digital healthcare technologies, says Michael L. Hodgkins, M.D., chief medical officer for the American Medical Association. View the slideshow for more information.
The AMA’s chief information officer talks digital health technology with Dermatology Times.
Diet can affect skin conditions including acne, atopic dermatitis, psoriasis and rosacea. In a review that focuses on these four conditions, plus aging, Rajani Katta, M.D., and Mary Jo Kramer, B.S., writing in Skin Therapy Letter, highlight trigger foods that should be avoided.
There are two important reasons why physicians should consider the role of diet in triggering psoriasis flares, says a leading expert.
The Food and Drug Administration (FDA) has approved rare pediatric disease designation for diacerein 1 percent ointment (CPP-020, Castle Creek Pharmaceuticals) for the treatment of epidermolysis bullosa (EB).
A study of the role of interleukin-25 (IL-25) in psoriasis demonstrated the cytokine is involved in propelling skin inflammation in psoriasis, according to a recent analysis.
The subcutaneous formulation of Actemra (tocilizumab, Genentech) has been approved by the Food and Drug Administration (FDA) for the treatment of polyarticular juvenile idiopathic arthritis (PJIA) in patients ages 2 years and older, accor
Belgian pharmaceutical firm UCB has entered the immunodermatology field in the U.S. market.